SILO PHARMA, INC. Deferred Compensation Equity
SILO PHARMA, INC. (SILO) had Deferred Compensation Equity of $0 as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2025-03-28
- 2024-12-31: Deferred Compensation Equity $0.00.
- 2024-09-30: Deferred Compensation Equity $0.00.
- 2024-06-30: Deferred Compensation Equity $0.00.
- 2023-12-31: Deferred Compensation Equity $14.13K.
| Period end | Deferred Compensation Equity | Deferred Compensation Equity as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-28 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $14.13K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $8.47K 10-Q · filed 2024-11-12 | $12.71K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.47K 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $4.24K 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $111.01K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $95.92K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $60.12K 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $45.01K 10-Q · filed 2023-05-12 | $49.91K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |